A Collaborative Initiative for Health Export Growth

HealthCatalyst comprising Norway Health Tech, Oslo Cancer Cluster, Validé (Norwegian Smart Care Cluster), and The Life Science Cluster work together with Innovation Norway and the rest of team Norway to implement the Norwegian government’s health initiative in Germany under the national export reform program, The Whole of Norway Exports.

Germany has been identified as a priority market for Norwegian health technology companies seeking to scale their international presence. This initiative will concentrate on a curated group of companies with established export revenues and strong potential for growth in Germany. These companies, collectively referred to as the landslagsliste by Innovation Norway, will receive targeted support to strengthen their market position and accelerate export expansion. See what Innovation Norway says about the inititative

Targeted Support for Norwegian Companies

To ensure a need driven approach Healthcatalyst performed 1:1 interviews with all companies on the ‘landslagsliste’. Building on this input HealthCatalyst in collaboration with Innovation Norway, the embassy and Team Norway in Germany have launched several initiatives, addressing the needs and areas below:

1. Market Entry Barriers and Roadmap

Please save the dates for our upcoming webinar and workshop series (also see calendar invites and detailed invitations sent by us)):

Delivered:

• June 4, 2025 | 11:30–12:45 (Webinar): Understanding the German Healthcare System: Structures, Changes & Implications - Material from the meeting can be found here

Save the Date:

• Sept 16, 2025 | 14:00–16:00: Regulatory Landscape: DIGA & Hospital Reform (combined with physical meeting of the landslagsliste)

• Oct 17, 2025 (Berlin): High-Level Roundtable on “OUTPATIENTIZSATION”, Felleshus at Nordic Embassies

• Nov 5, 2025 | 11:30–12:45 (Digital Roundtable)): Reimbursement System: Changes & Strategies to Address Underfunding

• Dec 4, 2025 | 15:00–20:00 (In-Person Workshop): Boosting Sales Expertise & Success, followed by networking

2. Industry Events & Side Programs
Join us at key industry events, which will include receptions and side events:

Delivered:

• Minister meeting in Berlin at Charité and the Norwegian Ambassadors residence, January 28-29 in Berlin
• DMEA: April 8-10, 2025, Berlin (Pavillion at the conference and Nordic Night event at the Nordic House)

Save the Date:

• ESMO 2025 Satellite Program, Oct 17^th, 2025 in Berlin: See Roundtable above, complemented by Evening Reception

• BioEurope: Nov 3–5, 2025, Vienna (TBC)
• Medica: Nov 17–20, 2025, Düsseldorf (Side event)
  More details will follow via email.

3. Study Trips & Delegation Visits (Workpackage 3)
To tailor meaningful visits, we need your input. Let us know:

• Who would you like to meet in Germany and/or host in Norway?
• Suggestions for study trips or other formats opening novel doors that will bring value to you company

We are happy to set up a short call to discuss your ideas.

Save the Date: Study Trips / Trade Mission around DMEA 2026 under discussion

4. Framework Conditions in the Norwegian market.
While this is a secondary part of the project, we recognize its importance and will continue advocating for better framework conditions building on your input.

We are looking forward to continuing our collaboration, please call or mail with questions or suggestions to:

Project manager: Arild Kristensen, Norway Health Tech, arild.kristensen@norwayhealthtech.com +47 90532591

Jutta Heix, Oslo Cancer Cluster, jh@oslocancercluster.no +47 94163089

Trine Radmann, Norway Health Tech, trine.radmann@norwayhealthtech.com + 47 99269285

Martin Nietz, Innovation Norway Germany, martin.nietz@innovationnorway.no +49171 4260170

Tone Varslot Stave, Innovation Norway Oslo, tone.varslot.stave@innovationnorway.no +4795225533